A
Adaptimmune Therapeutics plc (ADAPY)
0.03
0.00 (0.00%)
Find any stock by ticker or company name

0.03
0.00 (0.00%)
Adaptimmune Therapeutics plc engages in research, development, and subsequent manufacture and commercialisation of cell therapies to treat cancer in the United States and the United Kingdom. The company was founded in 2008 and is headquartered in Abingdon, the United Kingdom.
There is no data to display
There is no data to display